(Q86591090)
English
AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial
scientific article published on 23 October 2013
Statements
AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57) (English)
Nihar R Desai
Jing Zhou
Payal Kohli
Ransi Somaratne
Elaine Hoffman
Thomas Liu
Robert Scott
Scott M Wasserman
Marc S Sabatine
23 October 2013